The Future of JAKs in Dermatology
Dermatologists weigh in on the benefits and potential drawbacks of prescribing JAK inhibitors. With Ted Rosen, MD, FAAD “A number of cytokine receptors signal via JAK1, 2, 3 and TYK2, collectively known as janus kinases (JAKs) and their associated signal transducer and activators of transcription (STATs). JAK inhibition can simultaneously block the function of multiple, […]